Overview

• The Supreme Court’s Second Chamber ruled on July 2 that a specialized district court must formally register Cofece’s collective action lawsuit seeking 1.9 billion pesos in damages.
• Justices affirmed that the 2021 administrative sanctions and 903.4 million-peso fines imposed on Casa Marzam, Casa Saba and Fármacos Nacionales are final despite pending amparo proceedings.
• Cofece’s October 2024 claim earmarks the 1.9 billion pesos for IMSS-Bienestar to compensate public-health beneficiaries for inflated drug costs and reduced availability.
• Investigators found that major distributors colluded from 2006 to 2016 by restricting medicine supply, fixing prices and limiting discounts, causing over 2.4 billion pesos in sector-wide harm.
• The ruling paves the way for the new Comisión Nacional Antimonopolio to employ collective action remedies to defend consumer welfare.